Cheiradone: a vascular endothelial cell growth factor receptor antagonist
2008

Cheiradone: A Natural Antagonist of VEGF in Angiogenesis

publication Evidence: moderate

Author Information

Author(s): Hussain Sajjad, Slevin Mark, Mesaik Mohammad A, Choudhary Mohammad I, Elosta Abdul H, Matou Sabine, Ahmed Nessar, West David, Gaffney John

Primary Institution: Manchester Metropolitan University

Hypothesis

Does cheiradone inhibit VEGF-induced angiogenesis?

Conclusion

Cheiradone inhibits VEGF-induced angiogenesis by binding to VEGF receptors -1 and -2.

Supporting Evidence

  • Cheiradone inhibited VEGF-induced cell proliferation with IC50 values of 7.4 and 7.8 μM.
  • Cheiradone significantly inhibited VEGF-induced migration of endothelial cells.
  • In vivo, cheiradone completely abolished VEGF-induced blood vessel formation in the CAM assay.

Takeaway

Cheiradone is a natural substance that stops the growth of new blood vessels by blocking a specific signal that tells cells to grow.

Methodology

The study used in vitro and in vivo models to test the effects of cheiradone on VEGF-induced angiogenesis.

Limitations

The study did not explore the long-term effects of cheiradone or its interactions with other growth factors.

Statistical Information

P-Value

p<0.005

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2121-9-7

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication